Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-22 @ 5:23 PM
Study NCT ID:
NCT01902966
Status:
TERMINATED
Last Update Posted:
2021-10-12
First Post:
2013-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cervical Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Cervical Cancer | View |
| None | Propranolol | View |
| None | Betachron | View |
| None | Inderal | View |
| None | Beta blocker | View |
| None | Questionnaires | View |
| None | Surveys | View |
| None | Symptom inventory | View |
| None | Anxiety and depression survey | View |
| None | Pain inventory | View |
| None | Quality of life survey | View |
| None | Relaxation audio recording | View |
| None | MP3 player | View |
| None | Diary | View |